Upconversion Nanoparticles: on the Latest Three‐Stage Development of Nanomedicines Based on Upconversion Nanoparticles (adv. Mater. 21/2016)

Wenpei Fan,Wenbo Bu,Jianlin Shi
DOI: https://doi.org/10.1002/adma.201670141
IF: 29.4
2016-01-01
Advanced Materials
Abstract:The latest three-stage development of nanomedicines based on upconversion nanoparticles (UCNPs) in optimizing single treatment (e.g., NIR-triggered drug release, etc.), achieving multimodal synergetic therapy (e.g., chemo-/radiotherapy) and overcoming tumor hypoxia (e.g., disruption of hypoxic tumor, etc.) are discussed by W. Bu and co-workers on page 3987. Such UCNP-based nanomedicines may contribute significantly to promoting the clinic-translational applications of UCNP-based nanomedicines.
What problem does this paper attempt to address?